The BMC Office Based Addiction Treatment (OBAT) Program, also known as the “Massachusetts model,” is the pioneer in addiction treatment integrating nurse care managers into primary care settings. This national model specializes in substance use disorder treatment that also addresses medical needs. OBAT treats patients with state-of-the-art evidence-based medications and therapies for substance use while addressing social determinants of health, prevention, self-care, and primary medical needs. BMC OBAT is the largest hospital-based addiction treatment program in New England and continues to be recognized nationally and replicated within many outpatient settings.



  ### Office Based Addiction Treatment (OBAT)

- [Contact Us](#contact-us)
- [Treatments & Services](#treatments-services)
- [Our Team](#our-team)
- [Provider Resources](#provider-resources)
- [Research Overview](#research-overview)
- [Residency and Fellowship Information](#residency-and-fellowship-information)
 
   ## Contact Us

#####  Crosstown Center 

 

 [ 801 Massachusetts Ave., Boston, MA 02119   
5th Floor, Suite 5C   
BMC, Crosstown Center ](https://maps.app.goo.gl/xHWq2RQhAjbdbTFd8) 

 [617.414.4107](tel:617.414.4107) 

Monday - Tuesday 8:00 AM - 7:30 PM; Wednesday 9:00 AM - 7:30PM; Thursday 8:00AM – 5:30PM; Friday 9:00 AM – 5:30 PM

 

 

 [    ![](https://assets.bmc.org/transform/52184c85-c2c6-4047-b33d-aa7bf996c852/20140821ecBMC_1309?io=transform:fill,width:300,height:200&format=jpg)  

 ](/visiting-us/crosstown-building) 

 



 

  ## Treatments & Services

##### The BMC OBAT Program provides the following services to patients:

- [Family Medicine Center](https://www.bmc.org/family-medicine)
- [Addiction Psychiatry Treatment Program](https://www.bmc.org/programs/adult-outpatient-behavioral-health)
- [Center for Addiction Treatment for AdoLescent/Young adults who use SubsTances (CATALYST)](https://www.bmc.org/catalyst-clinic)
- Treatment for all types of substance use disorders, including opioid, alcohol, benzodiazepine, and stimulant use disorders
- Trained addiction experts, including nurses, physicians, nurse practitioners, social workers, psychiatrists, patient care coordinators, medical assistants, and recovery coaches
- Medications for opioid use disorder (MOUD): buprenorphine (Suboxone), injectable buprenorphine (Sublocade), and naltrexone (Vivitrol, Revia)
- Same-day medication access
- Direct telephone access to the nursing team
- Compassionate and non-judgmental care
- Harm reduction services and resources
- Specialized services to justice-involved individuals, adolescents, pregnant and post-partum women, and those with brain injuries
- Assistance accessing social supports and other benefits (e.g., food, IDs, employment, insurance)
- Behavioral health and psychiatric services
- Access to short- and long-term birth control
- Screening and treatment options for HIV, hepatitis A, B, and C, and sexually transmitted infections (STI)
- Overdose education and access to naloxone (Narcan)



  ## Our Team

### Leadership Team

**Colleen Labelle, MSN, RN-BC, CARN**  
*Program Director*

**Emily Hurstak, MD, MPH, MAS**  
*Medical Director*

**Lexie Bergeron, MPH, LCSW**  
*Director of Operations*



 

 

 

 

 



 

  ## Provider Resources

  [### Grayken Center for Addiction Training and Technical Assistance (TTA)

 The Grayken TTA provides education, support, and capacity building to community health centers, clinicians, social service providers, harm reduction specialists, families and more. Our training and technical assistance focuses on serving the Commonwealth, and has reached an international audience, training more than 25,000 individuals annually. Our trainings share best practices on caring for patients with substance use disorders, with the goal of expanding access and improving the quality of lifesaving, evidence-based treatment. 

 

 

 ](/office-based-addiction-treatment-obat/tta) 

  ## Research Overview

[**Office-Based Addiction Treatment Retention and Mortality Among People Experiencing Homelessness**](https://pubmed.ncbi.nlm.nih.gov/33662132/) - Fine DR, Lewis E, Weinstock K, Wright J, Gaeta JM, Baggett TP. \[published correction appears in JAMA Netw Open. 2021 Aug 2;4(8):e2128112\]. *JAMA Netw Open*. 2021;4(3):e210477. Published 2021 Mar 1. doi:10.1001/jamanetworkopen.2021.0477

[**Tapering off and returning to buprenorphine maintenance in a primary care Office Based Addiction Treatment (OBAT) program.**](https://pubmed.ncbi.nlm.nih.gov/29958128/) - Weinstein ZM, Gryczynski G, Cheng DM, et al.[ ](https://pubmed.ncbi.nlm.nih.gov/29958128/)*Drug Alcohol Depend*. 2018;189:166-171. doi:10.1016/j.drugalcdep.2018.05.010

[**Addiction Nursing Competencies: A Comprehensive Toolkit for the Addictions Nurse**](https://pubmed.ncbi.nlm.nih.gov/34411061/) - Wason K, Potter A, Alves J, et al. . *J Nurs Adm*. 2021;51(9):424-429. doi:10.1097/NNA.0000000000001041



  ## Residency and Fellowship Information

##### Addiction Medicine Fellowship

The mission of the Grayken Fellowship in Addiction Medicine is to train physician addiction medicine leaders in clinical care, research, education, public health, and advocacy to improve addiction care for people vulnerable to health inequities due to race, ethnicity, gender, poverty, age, disability, or stigmatizing illness.

The Grayken Addiction Medicine Fellowship Program is a one or two-year fellowship. There are also a three-year combined Infectious Disease-Addiction Medicine Fellowship and a two-year Fellowship in Maternal Health Addiction. Fellows are mentored by our multidisciplinary faculty from Internal Medicine, Infectious Disease, Emergency Medicine, Obstetrics & Gynecology, and Addiction Psychiatry. The Grayken Fellowship in Addiction Medicine is accredited by the ACGME. [**Click here to learn more**](https://www.bumc.bu.edu/care/education-and-training-programs/care-program-fellowship-in-addiction-medicine/).